Related Experiment Videos
Coronary artery bypass grafting in patients with hypopituitarism
T Yasuda1, M Kawasuji, Y Ishida
1Department of Surgery I, Kanazawa University School of Medicine, Japan. yasuda@sf.m.kanazawa-u.ac.jp
Japanese Circulation Journal
|March 25, 2000
Insights
Patients with hypopituitarism undergoing heart surgery require careful hormone replacement therapy. Steroid and thyroid hormone management during surgery prevents complications in these high-risk patients.
Area of Science:
- Cardiology
- Endocrinology
- Surgical Management
Background:
- Hypopituitarism presents complex challenges for patients requiring cardiac surgery.
- Coronary artery bypass grafting (CABG) is a critical intervention for ischemic heart disease.
Observation:
- Three patients with both angina pectoris and hypopituitarism underwent CABG.
- These patients received comprehensive perioperative hormonal management.
Findings:
- The study observed no complications in patients receiving perioperative steroid and thyroid hormone replacement.
- Successful surgical outcomes were achieved with meticulous hormonal support.
Implications:
- This case series highlights the necessity of precise perioperative hormonal management in hypopituitary patients undergoing CABG.
- Optimized endocrine support is crucial for mitigating risks and ensuring patient safety in this population.
Abstract:
Three patients with angina pectoris and hypopituitarism underwent coronary artery bypass grafting. The patients received perioperative replacement steroid and thyroid hormone therapy, and there were no complications. Careful perioperative hormonal management is necessary for patients with hypopituitarism.